Literature DB >> 3106195

Frequency analysis of augmented CTL production associated with Corynebacterium parvum-induced tumour regression.

T R Johnson, R J North.   

Abstract

A limiting-dilution frequency assay was employed to estimate the increased production of cytolytic T lymphocytes (CTL) associated with Corynebacterium parvum-induced regression of the P815 mastocytoma growing subcutaneously in semisyngeneic mice. It was found that intratumour C. parvum functioned to augment greatly the underlying concomitant production of CTL that occurs normally in response to a progressively growing untreated immunogenic tumour. The lymph node draining a C. parvum-treated tumour contained about eight times more CTL than the lymph node draining a control tumour. Intratumour C. parvum also caused a large increase in CTL production in the spleen and an increase in the number of CTL that could accumulate in a peritoneal exudate. At the peak of the anti-tumour response, the largest number of CTL was found in the draining lymph node (1.66 X 10(5], followed by the spleen (3.47 X 10(4) and by a 24-hr casein-induced peritoneal exudate (6.01 X 10(3]. Presumably, this greatly augmented production of CTL explains why C. parvum given intralesionally early enough during tumour growth can cause the regression of the weakly immunogenic P815 mastocytoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106195      PMCID: PMC1453263     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

Review 1.  Down-regulation of the antitumor immune response.

Authors:  R J North
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

Review 2.  Antitumor activity of Corynebacterium parvum.

Authors:  L Milas; M T Scott
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

3.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

4.  T cell responses to alloantigens. I. Studies of in vivo and in vitro immunologic memory and suppression by limit dilution analysis.

Authors:  R C Burton; J L Fortin; P S Russell
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

5.  In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.

Authors:  F Takei; J G Levy; D G Kilburn
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

6.  Mechanisms of anti-tumor action of Corynebacterium parvum. II. Potentiated cytolytic T cell response and its tumor-induced suppression.

Authors:  C D Mills; R J North; E S Dye
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

7.  Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.

Authors:  E S Dye; R J North; C D Mills
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

8.  Characterization of suppressor cells in mice bearing syngeneic mastocytoma.

Authors:  F Takei; J G Levy; D G Kilburn
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

9.  The peritoneal exudate lymphocyte. I. Differences in antigen responsiveness between peritoneal exudate and lymph node lymphocytes from immunized guinea pigs.

Authors:  D L Rosenstreich; J T Blake; A S Rosenthal
Journal:  J Exp Med       Date:  1971-11-01       Impact factor: 14.307

10.  Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors.

Authors:  K T Brunner; H R MacDonald; J C Cerottini
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  4 in total

1.  Sublethal, whole-body ionizing irradiation can be tumor promotive or tumor destructive depending on the stage of development of underlying antitumor immunity.

Authors:  M Awwad; R J North
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

2.  Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity.

Authors:  S K Hoover; S K Barrett; T M Turk; T C Lee; H D Bear
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Effect of advanced aging on ability of mice to cause regression of an immunogenic lymphoma in response to immunotherapy based on depletion of suppressor T cells.

Authors:  P L Dunn; R J North
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.

Authors:  M Awwad; R J North
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.